Aphasia – Wikipedia, the free encyclopedia

Aphasia is a combination of a speech and language disorder caused by damage to the brain that affects about one million individuals within the US.[1][2][3] Most often caused by a cerebral vascular accident (CVA), which is also known as a stroke, aphasia can cause impairments in speech and language modalities. To be diagnosed with aphasia, a person's speech or language must be significantly impaired in one (or several) of the four communication modalities following acquired brain injury or have significant decline over a short time period (progressive aphasia). The four communication modalities are auditory comprehension, verbal expression, reading and writing, and functional communication.

The difficulties of people with aphasia can range from occasional trouble finding words to losing the ability to speak, read, or write; intelligence, however, is unaffected.[1] Aphasia also affects visual language such as sign language.[2] In contrast, the use of formulaic expressions in everyday communication is often preserved.[4] One prevalent deficit in the aphasias is anomia, which is a deficit in word finding ability.[5]

The term "aphasia" implies that one or more communication modalities have been damaged and are therefore functioning incorrectly. Aphasia does not refer to damage to the brain that results in motor or sensory deficits, as it is not related to speech (which is the verbal aspect of communicating) but rather the individuals language. An individual's "language" is the socially shared set of rules as well as the thought processes that go behind verbalized speech. It is not a result of a more peripheral motor or sensory difficulty, such as paralysis affecting the speech muscles or a general hearing impairment.

Aphasia is from Greek a- ("without") + phsis (, "speech"). The word aphasia comes from the word aphasia, in Ancient Greek, which means[6] "speechlessness",[7] derived from aphatos, "speechless"[8] from - a-, "not, un" and phemi, "I speak".

Aphasia is most often caused by stroke, but any disease or damage to the parts of the brain that control language can cause aphasia. Some of these can include brain tumors, traumatic brain injury, and progressive neurological disorders.[10] In rare cases, aphasia may also result from herpesviral encephalitis.[11] The herpes simplex virus affects the frontal and temporal lobes, subcortical structures, and the hippocampal tissue, which can trigger aphasia.[12] In acute disorders, such as head injury or stroke, aphasia usually develops quickly. When caused by brain tumor, infection, or dementia, it develops more slowly.[1][13][14]

There are two types of strokes: ischemic stroke and hemorrhagic stroke. An ischemic stroke happens when a persons artery which supplies blood to different areas of the brain becomes blocked with a blood clot. This type of stroke happens 80% of the time. The blood clot may form in the blood vessel which is called a thrombus or the blood clot can travel from somewhere else in the blood system that is called an embolus. A hemorrhagic stroke occurs when a blood vessel in the brain ruptures or bursts. Overall, people experience bleeding inside or around brain tissue. This type of stroke happens 20% of the time and is very serious. The most common cause of hemorrhagic stroke is an aneurysm.

Although all of the diseases listed above are potential causes, aphasia will generally only result when there is substantial damage to the left hemisphere (responsible for language function) of the brain, either the cortex (outer layer) and/or the underlying white matter.

Substantial damage to tissue anywhere within the region shown in blue on the figure below can potentially result in aphasia.[15] Aphasia can also sometimes be caused by damage to subcortical structures deep within the left hemisphere, including the thalamus, the internal and external capsules, and the caudate nucleus of the basal ganglia.[16][17] The area and extent of brain damage or atrophy will determine the type of aphasia and its symptoms.[1][13] A very small number of people can experience aphasia after damage to the right hemisphere only. It has been suggested that these individuals may have had an unusual brain organization prior to their illness or injury, with perhaps greater overall reliance on the right hemisphere for language skills than in the general population.[18][19]

Primary Progressive Aphasia (PPA), while its name can be misleading, is actually a form of dementia that has some symptoms closely related to several forms of aphasia. It is characterized by a gradual loss in language functioning while other cognitive domains are mostly preserved, such as memory and personality. PPA usually initiates with sudden word-finding difficulties in an individual and progresses to a reduced ability to formulate grammatically correct sentences (syntax) and impaired comprehension. The etiology of PPA is not due to a stroke, traumatic brain injury (TBI), or infectious disease; it is still uncertain what initiates the onset of PPA in those affected by it.[20]

Finally, certain chronic neurological disorders, such as epilepsy or migraine, can also include transient aphasia as a prodromal or episodic symptom.[21] Aphasia is also listed as a rare side-effect of the fentanyl patch, an opioid used to control chronic pain.[22][23]

Aphasia is best thought of as a collection of different disorders, rather than a single problem. Each individual with aphasia will present with their own particular combination of language strengths and weaknesses. Consequently, it is a major challenge just to document the various difficulties that can occur in different people, let alone decide how they might best be treated. Most classifications of the aphasias tend to divide the various symptoms into broad classes. A common approach is to distinguish between the fluent aphasias (where speech remains fluent, but content may be lacking, and the person may have difficulties understanding others), and the nonfluent aphasias (where speech is very halting and effortful, and may consist of just one or two words at a time).

However, no such broad-based grouping has proven fully adequate. There is a huge variation among patients within the same broad grouping, and aphasias can be highly selective. For instance, patients with naming deficits (anomic aphasia) might show an inability only for naming buildings, or people, or colors.[24]

It is important to note that there are typical difficulties with speech and language that come with normal aging as well. As we age language can become more difficult to process resulting in slowing of verbal comprehension, reading abilities and more likely word finding difficulties. With each of these though, unlike some aphasias, functionality within daily life remains intact.[25]

Localizationist approaches aim to classify the aphasias according to their major presenting characteristics and the regions of the brain that most probably gave rise to them.[26][27] Inspired by the early work of nineteenth century neurologists Paul Broca and Carl Wernicke, these approaches identify two major subtypes of aphasia and several more minor subtypes:

Recent classification schemes adopting this approach, such as the "Boston-Neoclassical Model" [26] also group these classical aphasia subtypes into two larger classes: the nonfluent aphasias (which encompasses Broca's aphasia and transcortical motor aphasia) and the fluent aphasias (which encompasses Wernicke's aphasia, conduction aphasia and transcortical sensory aphasia). These schemes also identify several further aphasia subtypes, including: Anomic aphasia, which is characterized by a selective difficulty finding the names for things; and Global aphasia where both expression and comprehension of speech are severely compromised.

Many localizationist approaches also recognize the existence of additional, more "pure" forms of language disorder that may affect only a single language skill.[29] For example, in Pure alexia, a person may be able to write but not read, and in Pure word deafness, they may be able to produce speech and to read, but not understand speech when it is spoken to them.

Although localizationist approaches provide a useful way of classifying the different patterns of language difficulty into broad groups, one problem is that a sizeable number of individuals do not fit neatly into one category or another.[30][31] Another problem is that the categories, particularly the major ones such as Broca's and Wernicke's aphasia, still remain quite broad. Consequently, even amongst individuals who meet the criteria for classification into a subtype, there can be enormous variability in the types of difficulties they experience.

Instead of categorizing every individual into a specific subtype, cognitive neuropsychological approaches aim to identify the key language skills or "modules" that are not functioning properly in each individual. A person could potentially have difficulty with just one module, or with a number of modules. This type of approach requires a framework or theory as to what skills/modules are needed to perform different kinds of language tasks. For example, the model of Max Coltheart identifies a module that recognizes phonemes as they are spoken, which is essential for any task involving recognition of words. Similarly, there is a module that stores phonemes that the person is planning to produce in speech, and this module is critical for any task involving the production of long words or long strings of speech. Once a theoretical framework has been established, the functioning of each module can then be assessed using a specific test or set of tests. In the clinical setting, use of this model usually involves conducting a battery of assessments,[32][33] each of which tests one or a number of these modules. Once a diagnosis is reached as to the skills/modules where the most significant impairment lies, therapy can proceed to treat these skills.

In practice, the cognitive neuropsychological approach can be unwieldy due to the wide variety of skills that can potentially be tested. Also, it is perhaps best suited to milder cases of aphasia: If the person has little expressive or receptive language ability, sometimes test performance can be difficult to interpret. In practice, clinicians will often use a blend of assessment approaches, which include broad subtyping based on a localizationist framework, and some finer exploration of specific language skills based on the cognitive neuropsychological framework.

Primary progressive aphasia (PPA) is a focal dementia that can be associated with progressive illnesses or dementia, such as frontotemporal dementia / Pick Complex Motor neuron disease, Progressive supranuclear palsy, and Alzheimer's disease, which is the gradual process of progressively losing the ability to think. Gradual loss of language function occurs in the context of relatively well-preserved memory, visual processing, and personality until the advanced stages. Symptoms usually begin with word-finding problems (naming) and progress to impaired grammar (syntax) and comprehension (sentence processing and semantics). People suffering from PPA may have difficulties comprehending what others are saying. They can also have difficulty trying to find the right words to make a sentence.[34][35][36] There are three classifications of Primary Progressive Aphasia: Progressive nonfluent aphasia (PNFA), Semantic Dementia (SD), and Logopenic progressive aphasia (LPA)[36][37]

Progressive Jargon Aphasia is a fluent or receptive aphasia in which the patient's speech is incomprehensible, but appears to make sense to them. Speech is fluent and effortless with intact syntax and grammar, but the patient has problems with the selection of nouns. Either they will replace the desired word with another that sounds or looks like the original one or has some other connection or they will replace it with sounds. As such, patients with jargon aphasia often use neologisms, and may perseverate if they try to replace the words they cannot find with sounds. Substitutions commonly involve picking another (actual) word starting with the same sound (e.g., clocktower - colander), picking another semantically related to the first (e.g., letter - scroll), or picking one phonetically similar to the intended one (e.g., lane - late).

There have been many instances showing that there is a form of aphasia among deaf individuals. Sign language is, after all, a form of communication that has been shown to use the same areas of the brain as verbal forms of communication. Mirror neurons become activated when an animal is acting in a particular way or watching another individual act in the same manner. These mirror neurons are important in giving an individual the ability to mimic movements of hands. Broca's area of speech production has been shown to contain several of these mirror neurons resulting in significant similarities of brain activity between sign language and vocal speech communication. Facial communication is a significant portion of how animals interact with each other. Humans use facial movements to create, what other humans perceive, to be faces of emotions. While combining these facial movements with speech, a more full form of language is created which enables the species to interact with a much more complex and detailed form of communication. Sign language also uses these facial movements and emotions along with the primary hand movement way of communicating. These facial movement forms of communication come from the same areas of the brain. When dealing with damages to certain areas of the brain, vocal forms of communication are in jeopardy of severe forms of aphasia. Since these same areas of the brain are being used for sign language, these same, at least very similar, forms of aphasia can show in the Deaf community. Individuals can show a form of Wernicke's aphasia with sign language and they show deficits in their abilities in being able to produce any form of expressions. Broca's aphasia shows up in some patients, as well. These individuals find tremendous difficulty in being able to actually sign the linguistic concepts they are trying to express.[38]

People with aphasia may experience any of the following behaviors due to an acquired brain injury, although some of these symptoms may be due to related or concomitant problems such as dysarthria or apraxia and not primarily due to aphasia. Aphasia symptoms can vary based on the location of damage in the brain. Signs and symptoms may or may not be present in individuals with aphasia and may vary in severity and level of disruption to communication.[39] Often those with aphasia will try to hide their inability to name objects by using words like thing. So when asked to name a pencil they may say it is a thing used to write.[40]

Given the previously stated signs and symptoms the following behaviors are often seen in people with aphasia as a result of attempted compensation for incurred speech and language deficits:

Acute aphasias

The following table summarizes some major characteristics of different acute aphasias:

Subcortical aphasias

Most acute aphasia patients can recover some or most skills by working with a speech-language pathologist. This rehabilitation can take two or more years and is most effective when begun quickly. After the onset of Aphasia, there is approximately a six-month period of spontaneous recovery. During this time, the brain is attempting to recover and repair the damaged neurons. Therapy for Aphasia during this time facilitates an even greater level of recovery than if no intervention was given at this time.[44] Improvement varies widely, depending on the aphasia's cause, type, and severity. Recovery also depends on the patient's age, health, motivation, handedness, and educational level.[13]

There is no one treatment proven to be effective for all types of aphasias. The reason that there is no universal treatment for aphasia is because of the nature of the disorder and the various ways it is presented, as explained in the above sections. Aphasia is rarely exhibited identically, implying that treatment needs to be catered specifically to the individual. Studies have shown that, although there is no consistency on treatment methodology in literature, there is a strong indication that treatment in general has positive outcomes.[45] Therapy for aphasia ranges from increasing functional communication to improving speech accuracy, depending on the person's severity, needs and support of family and friends.[46] Group therapy allows individuals to work on their pragmatic and communication skills with other individuals with aphasia, which are skills that may not often be addressed in individual one-on-one therapy sessions. It can also help increase confidence and social skills in a comfortable setting.[47]

A multi-disciplinary team, including doctors (often a physician is involved, but more likely a clinical neuropsychologist will head the treatment team), physiotherapist, occupational therapist, speech-language pathologist, and social worker, works together in treating aphasia. For the most part, treatment relies heavily on repetition and aims to address language performance by working on task-specific skills. The primary goal is to help the individual and those closest to them adjust to changes and limitations in communication.[45]

Treatment techniques mostly fall under two approaches:

Several treatment techniques include the following:

Melodic Intonation Therapy is used to treat non-fluent aphasia and has proved to be effective in some cases.[52] However, there is still no evidence from randomized controlled trials confirming the efficacy of MIT in chronic aphasia. MIT is used to help people with aphasia vocalize themselves through speech song which is then transferred as a spoken word. Good candidates for this therapy include left hemisphere stroke patients, non-fluent aphasias such as Broca's, good auditory comprehension, poor repetition and articulation, and good emotional stability and memory.[53] It has been hypothesized that MIT is effective because prosody and singing both rely on areas of the right hemisphere; it may be these right-hemisphere areas that are recruited for natural speech production after intensive training.[54] An alternative explanation is that the efficacy of MIT depends on neural circuits involved in the processing of rhythmicity and formulaic expressions (examples taken from the MIT manual: I am fine, how are you? or thank you); while rhythmic features associated with melodic intonation may engage primarily left-hemisphere subcortical areas of the brain, the use of formulaic expressions is known to be supported by right-hemisphere cortical and bilateral subcortical neural networks.[4][55]

More recently, computer technology has been incorporated into treatment options. A key indication for good prognosis is treatment intensity. A minimum of twothree hours per week has been specified to produce positive results.[56] The main advantage of using computers is that it can greatly increase intensity of therapy. These programs consist of a large variety of exercises and can be done at home in addition to face-to-face treatment with a therapist. However, since aphasia presents differently among individuals, these programs must be dynamic and flexible in order to adapt to the variability in impairments. Another barrier is the capability of computer programs to imitate normal speech and keep up with the speed of regular conversation. Therefore, computer technology seems to be limited in a communicative setting, however is effective in producing improvements in communication training.[56]

The intensity of aphasia therapy is determined by the length of each session, total hours of therapy per week, and total weeks of therapy provided. There is no consensus about what intense aphasia therapy entails, or how intense therapy should be to yield the best outcomes. Overall, treatment is considered more intense when total therapy hours per week are increased, and on average, research suggests more intense therapy leads to better outcomes. For example, one study found that patients who were treated for 8.8 hours a week for 11.2 weeks progressed more than patients who were treated 2 hours a week for 22.9 weeks.[57] Results of another study corroborate these findings. The researchers found that patients who received intensive therapy of 100 treatment hours over 62 weeks scored higher on language measures than the control group who received less intensive therapy.[58] Therefore, although there is a general consensus that intense treatment encourages more improvement, there is not a straightforward definition of intense treatment.

Intensity of treatment should be individualized based on the recency of stroke, therapy goals, and other patient-specific characteristics such as age, size of lesion, overall health status, and motivation.[59][60] Each individual reacts differently to treatment intensity and is able to tolerate treatment at different times post-stroke.[61] Some patients cannot tolerate therapy directly after a stroke due to confusion or exhaustion, but may tolerate therapy better later. Intensity of treatment after a stroke should be dependent on the patients motivation, stamina, and tolerance for therapy.[61] Level of intensity also depends on therapy goals; for certain goals non-intensive therapy is more beneficial. For example, non-intensive therapy has been found to be more effective than intensive therapy when targeting naming accuracy in patients with anomia.[60] This is because more time in between sessions allows for rehearsal and reinforces long term learning.[60]

Intensity of therapy is also dependent on the recency of stroke. Patients react differently to intense treatment in the acute phase (03 months post stroke), sub-acute phase (36 months post stroke), or chronic phase (6+ months post stroke). Intensive therapy has been found to be effective for patients with nonfluent and fluent chronic aphasia, but less effective for patients with acute aphasia.[59][62] Patients with sub-acute aphasia also respond well to intensive therapy of 100 hours over 62 weeks. This suggests patients in the sub-acute phase can improve greatly in language and functional communication measures with intensive therapy compared to regular therapy.[58] Research suggests that intense treatment is most beneficial in the sub-acute or chronic phase, rather than directly post stroke.[58][59][62] More research needs to be done to examine the optimal time for providing intense therapy to all aphasic patients.[59]

Intensive therapy can be alternatively characterized by the magnitude of the demands placed on a client within a session. Under this definition, intensive therapy includes a few specific techniques such as Constraint Induced Aphasia Therapy (CIAT) and Speech Intensive Rehabilitation Intervention (SP-I-R-IT). CIAT places high demands on the patient by restricting use of the strongest areas of the patients brain and requiring the weakest areas to work harder. Typical CIAT therapy sessions are intense and last for about 3 hours.[63] One study found that when given intensive CIAT therapy, participant performance in verbal communication in everyday life significantly improved. Each participant in the study also showed improvement on at least one subtest within the Aachen Aphasia Test; which assesses language performance and comprehension in aphasia patients. These results suggest that intensive CIAT therapy is effective in patients with moderate, fluent aphasias in the chronic stage of recovery.[62] SP-I-R-IT focuses heavily on speech production strategies and intervention. SPIRIT therapy has been found to be effective; patients participating in intensive SPIRIT therapy improved performance on standardized measures by 15% after 50 weeks of therapy.[58]

Overall, intensity of aphasia treatment is an area that requires more research. Current research suggests that intense treatment is effective, although the definition of intense is variable. Most importantly, intensity of treatment should be determined on a case by case basis and should depend upon recency of stroke and the patients stamina, tolerance for therapy, motivation, overall health status, and treatment goals.

There are several outcomes that contribute to a patient's overall outcomes once diagnosed with aphasia including: neuroplasticity, age, overall health status, and patient motivation. Neuroplasticity is the brain's capability of change in response to the environment. Neuroplaticity underlies normal processes such as: typical development, learning & maintaining performance while aging, and the brain's response to a severe injury.[64] Positive outcomes are most prominent when neuroplasticity is maximized for the aphasic patient, and is predicted by the patient's response to the other stated outcomes.[65] The patient's age directly impacts the neuroplasticity the brain can allow, the younger the patient is, the greater plasticity is.[64] Overall health status also greatly impacts outcomes in aphasic patients. If a patient has no underlying health problems, and is young, then they have better outcomes than someone who is older, has severe health issues (such as: obesity, heart disease, cancer, high blood pressure, etc.) in conjunction with aphasia.[65] However, the most important factor affecting the outcomes of a patient with aphasia is a patient's motivation. In order to be successful, regardless of the contributing outcomes, the patient must be highly motivated in order to make the most efficient outcomes. If the patient is not motivated to make positive outcomes in their life after being diagnosed with any type of aphasia, their prognosis to make great improvements is much less than someone who is highly motivated to make positive changes in their life.[64][65] All of these outcomes contribute to success in Wernicke's, Broca's, Global, and Conduction aphasia, and are detailed below:

Wernicke's Aphasia:

Wernickes is considered a more severe form of aphasia, and is more commonly seen in older populations. Wernickes aphasia has shown a high recovery rate and frequent evolution to other forms of aphasia. Though some cases of Wernickes aphasia has shown greater improvements than more mild forms of aphasia, people with Wernickes aphasia may not reach as high of a level of speech abilities as those with mild forms of aphasia.[66]

Broca's Aphasia:

(Brocas and Anomic):

The term, Anomic Aphasia, usually refers to patients whose only prevalent symptom is impaired word retrieval in speech and writing.[67] Typically, the spontaneous speech of a person with anomic aphasia is fluent and grammatically correct but contains many word retrieval failures. These failures lead to unusual pauses, talking around the intended word, or substituting the intended word for a different word.[67] Anomic aphasia is the mildest form of aphasia, indicating a likely possibility for better recovery.[68] Patients with Brocas aphasia may also have difficulty with word retrieval, or anomia. In addition, patients with Brocas aphasia comprehend spoken and written language better than they can speak or write. These patients self-monitor, are aware of their communicative impairments, and frequently try to repeat or attempt repairs.[67] The preceding factors discussed correlate with a good prognosis for patients with Brocas aphasia. Many patients with an acute onset of Brocas aphasia, eventually progress to milder forms of aphasia, such as conduction or anomic.[69]

Therapy for Expressive Aphasia (nonfluent) is beneficial, even for patients with severe nonfluent aphasia. A study conducted by Marangolo and co-workers (2013) administered conversational therapy to patients with severe nonfluent aphasia. The results of the study demonstrated a significant increase in the patients expressive language. The authors suggested that an intensive conversational therapy program should be considered for patients with moderately severe nonfluent aphasia in order to enhance the patient's quality of life and improve their language expression.[70] In addition, although Anomic Aphasia is seen to be less severe than other aphasias, therapy is still imperative to help decrease the patients word finding deficits. A research study conducted by Harnish and co-workers (2014), provided intense treatment to patients with anomic aphasia. Results of the study concluded significant increases in the participants expressive language. These results suggest that an intensive intervention program for patients with anomic aphasia provides a surprisingly quick expressive language increase. Specifically, these patients relearned to correctly produce the problematic words after one to three hours of speech-language therapy.[71]

Global Aphasia:

Global aphasia is considered a severe impairment in many language aspects since it impacts expressive and receptive language, reading, and writing.[72] Despite these many deficits, there is evidence that has shown individuals benefited from speech language therapy.[73] Even though each case is different, it has been noted that individuals with global aphasia had greater improvements during the second six months following the stroke when compared to the first 6 months.[74] Intense and frequent speech-language therapy had been shown to be more effective, with the addition of daily homework.[73] Improvement has also been shown when the individual was attentive, motivated, and information was presented in multiple ways.[75]

In one study, 23 individuals that had previously received speech-language therapy, but had been dismissed because further recovery was not expected, participated in intense speech-language therapy.[73] Results showed significant improvements in oral and written noun and sentence production, naming actions, and daily communication.[73]

Even though individuals with global aphasia will not become competent speakers, listeners, writers, or readers, goals can be created to improve the individuals quality of life.[67] Collins (1991) suggests therapy targeting attainable goals that will have the greatest impact on an individuals daily life, such as getting reliable yes/no answers or providing the patient gestures. Individuals with global aphasia usually respond well to treatment that includes personally relevant information, which is also important to consider for therapy.[67]

Conduction Aphasia:

Conduction and transcortical aphasias are caused by damage to the white matter tracts. These aphasias spare the cortex of the language centers, but instead create a disconnection between them.

Conduction aphasia is caused by damage to the arcuate fasciculus. The arcuate fasciculus is a white matter tract that connects Brocas and Wernickes areas. Patients with conduction aphasia typically have good language comprehension, but poor speech repetition and mild difficulty with word retrieval and speech production. Patients with conduction aphasia are typically aware of their errors.[67] The awareness of errors and the milder nature of conduction aphasia compared to other types contributes to a positive outcome. Additionally, a case study completed on a 54-year-old man with a large infarct in the arcuate fasciculus indicated that severe conduction aphasia can be successfully treated. Despite his global deficits, he made a full recovery after 30 months.[76]

Transcortical aphasias include transcortical motor aphasia, transcortical sensory aphasia, and mixed transcortical aphasia. Patients with transcortical motor aphasia typically have intact comprehension and awareness of their errors, but poor word finding and speech production. Patients with transcortical sensory and mixed transcortical aphasia have poor comprehension and unawareness of their errors.[67] Despite poor comprehension and more severe deficits in some transcortical aphasias, small studies have indicated that full recovery is possible for all types of transcortical aphasia.[77] Due to the limited research on outcomes for the specific subtypes of these aphasias, it is more important to focus on the other factors and severity of deficits in order to predict a reasonable outcome.

The first recorded case of aphasia is from an Egyptian papyrus, the Edwin Smith Papyrus, which details speech problems in a person with a traumatic brain injury to the temporal lobe.[78] During the second half of the 19th century, Aphasia was a major focus for scientists and philosophers who were working in the beginning stages in the field of psychology.[2]

This section primarily repeats material that should be found in the page Stroke. Please add additional material or remove this section.

Please consider turning this section into a table.

150,074 people suffered a lethal stroke in the US in 2004. It is the third largest cause of death globally, ranking behind cardiovascular disease and all forms of cancer. Stroke is a leading cause of serious, long-term disability in the United States. About 5,800,000 stroke survivors are alive in the US today; 2,300,000 are males and 3,400,000 are females. Studies show that about 780,000 people suffer a new or recurrent stroke each year. About 600,000 of these are first attacks and 180,000 are recurrent attacks. In 2004, females accounted for 60.8 percent of stroke deaths. From 1994 to 2004 the death rate from stroke declined 24.2 percent, and the actual number of stroke deaths declined 6.8 percent.[citation needed]

Like the previous section, this section repeats material that should be found in the page Stroke. Please merge or delete this section.

Following are some precautions that should be taken to avoid aphasia, by decreasing the risk of stroke, the main cause of aphasia:

Here is the original post:
Aphasia - Wikipedia, the free encyclopedia

Department of Biochemistry, University of Oxford

Welcome to the Department of Biochemistry, part of the University of Oxford's Medical Sciences Division. We are one of the largest Biochemistry departments in the world and carry out world-class research and teaching. Our researchers come from a range of disciplines and work in a collaborative environment on all aspects of modern molecular and cellular biochemistry. We hope you enjoy reading more about our activities on these pages.

Professor Mark Sansom, Head of Department

A new paper from postdoctoral fellow Stephan Uphoff in the Biochemistry department has revealed that random variation in the DNA repair capacity of cells can lead to genetic variation.

E. coli cells treated with DNA methylation damage induce the adaptive response by activating Ada protein expression. The microscopy image shows fluorescently tagged Ada in yellow. Despite identical genetic makeup and treatment, a fraction of cells fails to induce the Ada response (in grey). Scale bar: 5 m (Click to Enlarge)

The results are published in Science (1) and are the fruition of a collaborative project between Dr Uphoff in Professor David Sherratt's lab and the lab of Professor Johan Paulsson at Harvard Medical School. They provide insight into how phenotypic variation can lead to genetic variation - a new twist on studies exploring the impact of variability in gene expression between cells.

A physicist by training, Dr Uphoff has spent the last few years developing and applying live cell imaging techniques. Currently funded by a Sir Henry Wellcome Postdoctoral Fellowship from the Wellcome Trust and a Junior Research Fellowship at St John's College in Oxford, he has been using single-molecule imaging to study mechanisms of DNA repair in bacteria, in both the Sherratt and Paulsson labs.

The newly published study explores the consequences of heterogeneity in a bacterial DNA repair process. Whilst there has been lots of discussion about noise in gene expression giving rise to phenotypic heterogeneity in genetically identical cells, there have been few studies that go beyond transient variations in gene expression. In the case of DNA repair, however, any transient heterogeneity could persist over long timescales in the form of mutations.

In the bacterium Escherichia.coli, the adaptive response protects cells against the toxic and mutagenic effects of DNA methylation damage. This requires Ada protein, which as well as directly repairing methylated DNA, also activates ada gene expression. It does this via a positive feedback mechanism - ada expression is increased a thousand-fold by methylated Ada which acts as a transcriptional activator after transfer of a methyl group from damaged DNA onto the protein during the repair process.

Another feature of the DNA damage response is that Ada protein is present in low numbers in cells before DNA damage. 'We hypothesised that there should be substantial heterogeneity in the adaptive response between cells because positive feedback tends to amplify the noise that is inherent in low molecule numbers,' says Dr Uphoff.

Read more

See the original post:
Department of Biochemistry, University of Oxford

What Is Integrative Medicine? – WebMD

Experts explore new ways to treat the mind, body, and spirit -- all at the same time.

What makes integrative medicine appealing? Advocates point to deep dissatisfaction with a health care system that often leaves doctors feeling rushed and overwhelmed and patients feeling as if they're nothing more than diseased livers or damaged joints. Integrative medicine seems to promise more time, more attention, and a broader approach to healing -- one that is not based solely on the Western biomedical model, but also draws from other cultures.

"Patients want to be considered whole human beings in the context of their world," says Esther Sternberg, MD, a National Institutes of Health senior scientist and author of The Balance Within: The Science Connecting Health and Emotions.

Sternberg, a researcher who has done groundbreaking work on interactions between the brain and the immune system, says technological breakthroughs in science during the past decade have convinced even skeptics that the mind-body connection is real.

"Physicians and academic researchers finally have the science to understand the connection between the brain and the immune system, emotions and disease," she says. "All of that we can now finally understand in terms of sophisticated biology."

That newfound knowledge may help doctors to see why an integrative approach is important, she says.

"It's no longer considered fringe," Sternberg says. "Medical students are being taught to think in an integrated way about the patient, and ultimately, that will improve the management of illness at all levels."

The Osher Center for Integrative Medicine at the University of California, San Francisco, takes a similarly broad view of health and disease. The center, which includes a patient clinic, says on its web site: "Integrative medicine seeks to incorporate treatment options from conventional and alternative approaches, taking into account not only physical symptoms, but also psychological, social and spiritual aspects of health and illness."

To promote integrative medicine at the national level, the Osher Center and Duke have joined with 42 other academic medical centers -- including those at Harvard, Columbia, Georgetown, and the University of Pennsylvania -- to form the Consortium of Academic Health Centers for Integrative Medicine.

Read more from the original source:
What Is Integrative Medicine? - WebMD

Andrew Weil: Arizona Center for Integrative Medicine

Andrew Weil, MD

Founder & Program Director

Andrew Weil was born in Philadelphia in 1942, received an A.B. degree in biology (botany) from Harvard in 1964 and an M.D. from Harvard Medical School in 1968. After completing a medical internship at Mt. Zion Hospital in San Francisco, he worked a year with the National Institute of Mental Health, then wrote his first book, The Natural Mind. From 1971-75, as a Fellow of the Institute of Current World Affairs, Dr. Weil traveled widely in North and South America and Africa collecting information on drug use in other cultures, medicinal plants, and alternative methods of treating disease. From 1971-84 he was on the research staff of the Harvard Botanical Museum and conducted investigations of medicinal and psychoactive plants.

At present Dr. Weil is Director of the Center for Integrative Medicine of the College of Medicine, University of Arizona, where he also holds the Lovell-Jones Endowed Chair in Integrative Rheumatology and is Clinical Professor of Medicine and Professor of Public Health. The Center is the leading effort in the world to develop a comprehensive curriculum in integrative medicine. Graduates serve as directors of integrative medicine programs around the United States, and through its Fellowship, the Center is now training doctors and nurse practitioners around the world.

Under Dr. Weil's leadership, the Center has created two new programs for other health professionals including the Integrative Health and Lifestyle Program, and a certification program in Integrative Health Coaching.

Andrew Weil is the author of many scientific and popular articles and of 11 books, including: The Natural Mind; The Marriage of the Sun and Moon; From Chocolate to Morphine (with Winifred Rosen); Health and Healing; Natural Health, Natural Medicine; and the international bestsellers, Spontaneous Healing and Eight Weeks to Optimum Health. His most recent books are Eating Well for Optimum Health: The Essential Guide to Food, Diet, and Nutrition; The Healthy Kitchen: Recipes for a Better Body, Life, and Spirit (with Rosie Daley); Healthy Aging: A Lifelong Guide to Your Well-Being, and Why Our Health Matters: A Vision of Medicine that can Transform our Future, published in Sept. 2009. Oxford University Press is currently producing the Weil Integrative Medicine Library, a series of volumes for clinicians in various medical specialties; the first of these, Integrative Oncology (co-edited with Dr. Donald Abrams) appeared in 2009.

Dr. Weil also writes a monthly newsletter, Dr. Andrew Weil's Self Healing, maintains a popular website, Dr. Weil.com (www.drweil.com), and appears in video programs featured on PBS. He also writes a monthly column for Prevention magazine. Dr. Weil serves as the Director of Integrative Health at Miraval Life in Balance Resort in Catalina, Arizona. A frequent lecturer and guest on talk shows, Dr. Weil is an internationally recognized expert on medicinal plants, alternative medicine, and the reform of medical education. He lives near Tucson, Arizona, USA.

To contact Dr. Weil, please e-mail his assistant.

Read more from the original source:
Andrew Weil: Arizona Center for Integrative Medicine

Integrative Medicine – UMass Medical School – Worcester

An evolution in medical practice,integrative medicine supports the unique expression of health and vitality for every individual.If you have an interest in learningaboutnon-allopathic techniques, or if you already have training in them, the UMass Worcester Family Medicine Residency is the place to be!

We canhelp you get the training to be effective and supervise your use of these techniques. Whileyou are fine tuning your skills inWestern Medicine, you willgain extensive experience inthe practice of integrativemedicine:

Acupuncture: the ancient practice of using tiny needles to change the energy patterns of the body in order to restore balance and health.

Cupping: used to treat muscular joint pain as well as many systemic diseases. Uses hand-pump or heated cups to create local suction on the skin.

Functional Medicine: addressing the whole person, not just an isolated set of symptoms,practitioners gather extensive personal, medical and social histories. Then, they evaulate the interactions among genetic, environmental and lifestyle factors that can influence long-term health and complex, chronic disease.

GuaSha: also called "coining". Scraping the skin with a blunt tool (coin, spool or other instrument) to treat local pain or systemic problems.

Hypnosis: each day the human mind controls millions of events through the body. Using hypnosis, "inward focus," you can train your mind to influence many areas of function.

Natural Therapies: using non-prescription compounds such as Western or Chinese herbs, or vitamin and mineral supplements to restore balance and function.

Osteopathic Manipulation: OMT can help people of all ages and backgrounds. The treatment can be used to ease pain, promote healing and increase overall mobility .

"After practicing Family Medicine for a few years, I realized that Western medicine had little to offer many patients. I started looking into non-Western therapies and have become an Integrative Medicine Practitioner.Contact me anytime with questions!"Melissa Rathmell, MD, Director of Integrative Medicine UMass Family Medicine ResidencyTo learn more about Dr. Rathmell,we invite you toread our recent interview with her!

American Academy of Medical AcupunctureAmerican Osteopathic AssociationInstitute for Functional MedicineNew England Society of Clinical Hypnosis

Read more:
Integrative Medicine - UMass Medical School - Worcester

Complementary and Integrative Medicine

No. 101; April 2012

Complementary and integrative medicine, also called complementary and alternative medicine (CAM) refers to a wide array of health care practices not currently considered to be part of mainstream medicine. Widespread use of CAM for various conditions requires that families, patients and health care professionals have a basic understanding of CAM.

Definitions:

Basic Philosophies Include:

Complementary and Integrative Medicine and Children: A wide range of therapies are used in children including herbs, dietary supplements, massage, acupuncture, naturopathy and homeopathy.

The American Academy of Pediatrics (AAP) reports that families use CAM in 20-40 percent of healthy children and in over 50 percent of children with chronic, recurrent and incurable illnesses. Despite this high rate of CAM usage families frequently do not inform their healthcare providers of what treatments they are using. Some groups of children are more likely to use CAM than others. Parents who use CAM are more likely to treat their children with it. Children with chronic disabling or recurrent conditions are among those who have higher CAM use.

CAM usage by families where children have mental health diagnoses is widespread. Studies have suggested CAM usage at nearly 50 percent of children with autism and 20 percent of children with ADHD. Unfortunately, psychiatrists are informed of CAM usage less than 50 percent of the time.

Tips for Youth and Family:

When seeking care from a CAM practitioner, as with any healthcare provider, it is important to ask about the practitioner's:

Additional Information Can be Obtained from: The National Center for Complementary and Alternative Medicine and the National Institution of Health (NCCAM) Consortium of Academic Health Centers in Integrative Medicine (CAHCIM) Consumer Labs

See the original post here:
Complementary and Integrative Medicine

Nanomedicine Conferences| Nanotechnology conferences| 2016 …

Conference Series LLCinvites all the participants from all over the world to attend 10th International Conference on Nanomedicine and Nanotechnology in Health Care during July 25-27, 2016 at Avani Atrium, Bangkok, Thailand. It will include presentations and discussions to help attendees address the current trends and research on the applications of Nanomedicine and nanotechnology in healthcare. The theme of the conference is "Embarking Next Generation Delivery Vehicles for affordable Healthcare!"

Nanomedicineis innovating the healthcare industry and impacting our society, but is still in its infancy in clinical performance and applications. The aim of thisNanomedicine 2016conference is to bring together leading academic, clinical and industrial experts to discuss development of innovative cutting-edge Nanomedicine and challenges in Nanomedicine clinical translation.

Track 01:Nanomedicine

Nanomedicine applications in the field of medicine are vast. It helps in the detection, diagnosis, prevention, treatment and follow-up of many diseases.Personalized Nanomedicineis being applied in all the branches of medicine like Radiology, Neurology, Surgery, Pulmonology, Dentistry, Orthopaedics, Ophthalmology etc.Nanomedicine conferencesfocusses on how Nanomedicine can be the next delivery vehicle for making healthcare affordable.

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting

Nanomaterials Conference April 21-23 2016, UAE; MedicalNanotechnologySummit June 9-11 2016, Dallas; Molecular Nanoscience Meeting September 26-28 2016, UK; Nanotechnology Expo November 10-12 2016, Australia; Nanotech Expo December 5-7 2016, USA; International Conference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; International Conference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic; International Conference on Biotechnology, Bioengineering andNanoengineering, April 14-15, 2016, Portugal; Meeting and Expo onNanomaterialsand Nanotechnology, 25th - 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece, American Society For Nanomedicine, Washington, USA, Society for Personalized Nanomedicine, Florida, USA

Track 02: Nanomedicine and Drug delivery

There are a many ways thatnanotechnologycan make the delivery of drugs more systematic and accost effective treatment for the patient. Numerous biological materials like albumin, gelatine and phospholipids for liposomes, and more substances of a chemical nature like various polymers and solid metal containing nanoparticles are under investigation for preparation of nanoparticles. The hazards that are introduced by usingnanoparticles for drug deliveryare more than that posed by conventional hazards imposed by chemical delivery.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

Bioavailability and Bioequivalence Summit August 29-31, 2016, USA;Surgical OncologyConference during September 01-03, 2016, Brazil; Precision Medicine ConferenceNovember 03-05, 2016, USA; Translational MedicineConference November 17-19, 2016, USA;Mesothelioma Summit,November 03-04, 2016, Spain; International Conference onBiotechnologyand Nanotechnology, April 14-15, 2016, Portugal;Nanotech Conference & Exhibition, 01-03 June, 2016, France; Materials Scienceand Nanotechnology Conference July 28- 29, 2016, China; 7thInternationalnanotechnology Summit: fundamentals and applications, August 19-10, 2016 Hungary, Society for Personalized Nanomedicine, Florida, USA, European Society for Nanomedicine, Basel, Switzerland

Track 03:Nanomedicine and Nanotechnology

Nanomedicine is an emerging specialty born from Nanotechnology. Bothnanomedicine and nanotechnologyare emerging as the new direction in the diagnosis and drug therapy. Nanomedicine can change the face of healthcare in the future using nanotechnology.Nanomedicinehelps detect, repair, understand and control the human biological system. Nanomedicine can be used forpersonalized Nanomedicine.

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting:

Nanomaterials Conference April 21-23 2016, UAE; MedicalNanotechnologySummit June 9-11 2016, Dallas; Molecular Nanoscience Meeting September 26-28 2016, UK; Nanotechnology Expo November 10-12 2016, Australia; Nanotech Expo December 5-7 2016, USA; International Conference onNanoscienceand Nanotechnology (ICONN), 711 February 2016, Australia; International Conference onNanobiotechnology, Drug Delivery, and Tissue Engineering, 1st- 2ndApril 2016, Czech Republic, Biotechnology, Bioengineering andNanoengineering Conference, April 14-15, 2016, Portugal; Nanomaterials Conferenceand Nanotechnology, 25th - 27th April 2016, UAE;NANOTEXNOLOGY, 29 July, 2016, Greece, International Association of Nanotechnology, California, USA, French Society for Nanomedicine, Lille, France

Track 04:Nanomedicine and Nanobiotechnology

Nanobiotechnologyis the intersection of nanotechnology and biology. Nanobiotechnology has multitude of potentials for advancing medical science thereby improving health care practices around the world. Nanomedicine is used to treat diseases bygene therapy. Nano biotechnologies are being applied to molecular diagnostics and several technologies are in development.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

NanoConference June 20-21, 2016 Cape Town, South Africa; Medical NanotechnologyCongress and Expo June 9-11, 2016 Dallas, USA; Nanotechnology Congress June 27-29, 2016 Valencia, Spain; 11th Nanobiotechnology MeetingSeptember 26-28, 2016 London, UK: Nanotechnology Expo November 10-12, 2016 Melbourne, Australia: International Conference on NanotechnologyModellingand Simulation April 1-2, 2016 Prague, Czech Republic: The 5th Conference onNanomaterialsJanuary 14-16, 2016 Bangkok, Thailand: Nanotechnology Conference and Expo Baltimore, USA, 4th to 6th April 2016: 4thNanoscience Conference (ICNT2016) Kuala Lumpur, Malaysia, 28th - 29th January 2016: 4th Conference on Materials ScienceNew York, USA, American Nano Society, Florida, USA, Sustainable Nanotechnology Organization, Washington, USA

Track 05:Nanomedicine and Bioengineering

Nanomedicinehas a considerable role in Bioengineering. To design and construct an apt scaffold is the major challenge inRegenerative medicinetoday. The cell-cell and cell-matrix interactions in the biosystems happen at the nanoscale level. Therefore the application of nanotechnology at that level helps in modifying the cellular function to mimic the native tissue in a more appropriate way. The application ofBioengineeringhas transformed the designing the manufacturing of scaffolds and artificial grafts.

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting:

Stem Cell Research conference February 29-March 02 2016, USA, Bio banking ConferenceAugust 18-19 2016, USA; Regenerative Medicine Conference,September 12-14 2016, Germany; 6th Pharmacogenomics ConferenceSeptember 12-14, 2016, Berlin, Germany; Conference onRestorative MedicineOctober 24-26, 2016, USA ; Conference onRegeneration, January 10 14, 2016, USA; ISSCR Conference onNeural Degenerationand Disease, 18th Biotechnology Meeting, April 11-12, 2016, Italy; 14th European Symposium on Drug Delivery, 13th-15thApril 2016, The Netherlands Sustainable Nanotechnology Organization, Washington, USA, Asian Nanoscience and Nanotechnology Association, Kagawa, Japan

Track 06:Nanomedicine and Cancer

Cancer Nanomedicineaims to use the nanostructures and nanoscale processes for the prevention, detection, diagnosis and treatment of cancer and other concomitant areas. Even when molecular changes occur in a smaller percentage of cells, which may be cancer related targets.Nanomedicine in cancercan help in the sensitive detection of them. The use of Nanotechnology to combat cancer is still under development. Severalnanocarrierdrugs andnanotherapeuticsare available in market and some in Clinical trials.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

CancerDiagnostics Expo June 13-15 2016, Italy; Conference onCancer Immunologyand Immunotherapy July 28-30 2016, Australia;Cancer GenomicsSummit August 8-9 2016, USA; 12th Cancer TherapySummit September 26-28 2016, UK; International Conference onCervical CancerSeptember 22-23 2016, Austria; TheBiomarkerConference, 18th-19th February 2016, USA; Cancer Vaccines: Targeting Cancer Genes forImmunotherapy, March 610 2016, Canada; 18th Conference on Biotechnology Advances, April 11-12, 2016, Italy; 14th European Drug Delivery Summit, April 13-15 2016, The Netherlands; 18th InternationalCancer NanomedicineConference and Novel Drug Delivery Systems, April 22 - 23, 2016, United Kingdom, Asian Nanoscience and Nanotechnology Association, Kagawa, Japan, European Nanoscience and Nanotechnology Association, Bulgaria.

Track 07:Nanomedicine and Healthcare

Nanomedicineaffects almost all the aspects of healthcare. Nanomedicine helps to engineer novel and advanced tools for the treatment of various diseases and the improvement of human biosystems usingmolecular Nanotechnology. Cardiovascular diseases, Neurodegenerative disorders, Cancer, Diabetes, Infectious diseases, HIV/AIDS are the main diseases whose treatment can be benefitted by using nanomedicine.

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting:

Bioequivalence and Bioavailability Summit August 29-31, 2016, USA;Surgical OncologyConference during September 01-03, 2016, Brazil; Precision Medicine ConferenceNovember 03-05, 2016, USA; Translational MedicineConference November 17-19, 2016, USA;Mesothelioma Summit,November 03-04, 2016, Spain; International Conference onBiotechnologyand Nanotechnology, April 14-15, 2016, Portugal;Nanotech Conference & Exhibition, 01-03 June, 2016, France; Materials Scienceand Nanotechnology Conference July 28- 29, 2016, China; 7thInternationalnanotechnology Summit: fundamentals and applications, August 19-10, 2016 Hungary, Society for Personalized Nanomedicine, Florida, USA, European Society for Nanomedicine, Basel, Switzerland

Track 08:Nanomedicine and Healthcare Applications

Nanomedicineapplications in healthcare Industry are broad. It helps to engineer newNano medical devices, design nanoparticles for detection and drug delivery in cancer. Nanomedicine can be applied in allied areas of healthcare like Wound healing, Food Industry and Hair growth. Nanomedicine is being widely used forpublic health and Nutrition.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

NanoConference June 20-21, 2016 Cape Town, South Africa; Medical NanotechnologyCongress and Expo June 9-11, 2016 Dallas, USA; Nanotechnology Congress June 27-29, 2016 Valencia, Spain; 11th Nanobiotechnology MeetingSeptember 26-28, 2016 London, UK: Nanotechnology Expo November 10-12, 2016 Melbourne, Australia; International Conference on NanotechnologyModellingand Simulation April 1-2, 2016 Prague, Czech Republic: The 5th Conference onNanomaterialsJanuary 14-16, 2016 Bangkok, Thailand: Nanotechnology Conference and Expo Baltimore, USA, 4th to 6th April 2016: 4thNanoscience Conference (ICNT2016) Kuala Lumpur, Malaysia, 28th - 29th January 2016: 4th Conference on Materials ScienceNew York, USA, American Nano Society, Florida, USA, Sustainable Nanotechnology Organization, Washington, USA.

Track 09: Nanotechnology and Food

Nanotechnology has begun to find potential applications in the area of functional food by engineering biological molecules toward functions very different from those they have in nature, opening up a whole new area of research and development. Of course, there seems to be no limit to whatfood technologistsare prepared to do to our food and nanotechnology will give them a whole new set of tools to go to new extremes. Nanotechnology may revolutionize the food industry by providing stronger, high-barrier packaging materials, more potent antimicrobial agents, and a host of sensors which can detect trace contaminants, gasses or microbes in packaged foods.

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting:

Biopolymers Congress, August 01-03, 2016, UK; Conference onSustainable BioplasticsNovember 10-12, 2016, Spain; Biopolymers andBioplastics Summit, September 12-14, 2016, USA; Biofuelsand Bioenergy September 1-3, 2016, Brazil; Public HealthSummit March 10-12, 2016, Spain; 5th Annual PharmaceuticalMicrobiology Conference, 2021 January 2016, United Kingdom; 18th International Conference on Biomaterials,Colloidsand Nanomedicine, January 21-22, 2016, France; 13th National Conference and Technology Exhibition On Medical Devices &PlasticsDisposables, February 12-13, 2016, USA; 18th International Conference onToxicology, February 25 - 26, 2016; United Kingdom; Faraday Discussion:Nanoparticleswith Morphological and Functional Anisotropy, 46 July 2016, United Kingdom, Asian Nanoscience and Nanotechnology Association, Kagawa, Japan, European Nanoscience and Nanotechnology Association, Bulgaria

Track 10:Nanomedicine and Nanotheranostics

Nanotheranosticscombine both the Non-invasive diagnosis and treatment of diseases and helps to monitor the drug release and dispersion of the drug, thereby increasing the effectiveness of therapy.Cancer nanotheranosticshold a great promise in improving the treatment outcomes in Cancer. Nanotheranostics are currently being used in theBiomarker Discovery. Nanotheranostics include both Genomics based theranostics and Proteomics based theranostics

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

Pharmacology SummitAugust 08-10 2016, UK;Conference onClinical TrialsAugust 22-24 2016, USA; Neuropharmacology MeetingSeptember 15-17 2016, USA;PharmacovigilanceSummit September 19-21 2016 in Austria; Drug DiscoveryExpo October 24-26 2016, Turkey; 18th International Conference onBioengineering, Biotechnology and Nanotechnology, January 18 - 19, 2016, United Kingdom; 4thImmunogenicity& Immunotoxicity Conference January 25-26, 2016, USA; Genomics andpersonalized medicine conference, 07-11 February, 2016, Canada;Conference onAntibodiesas Drugs, 06-10 March, 2016, Canada; Pharmaceutical Sciences Congress, 28 August - 1 September 2016, Argentina, American Society For Nanomedicine , Washington, USA, Society for Personalized Nanomedicine, Florida, USA

Track 11: Nanomedicine and Nanobiology

Nano biologyis the branch where basic biology of the organism and nanotechnology meet. Nano biology helps in addressing the basic mechanisms of human health and diseases at the cellular and molecular level.Nano biologyapplied in microbiology is Nanomicrobiology. Recently certain nanoparticles are being designed to act against infections

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting:

Conference onPharmaceutics March 07-09 2016, Spain; BiosimilarsCongress June 27-29, 2016 Valencia, Spain; Drug DeliverySummit June 30- July 02 2016, USA; Conference onPharmaceuticalRegulatory Affairs and IPR September 12-14 2016, USA; Asia Pacific MassSpectrometryCongress October 10-12 2016, Malaysia;Advanced MaterialsConference (IC2NAM), January 15th 2016; New Zealand; Modern PhenotypicDrug Discovery Summit: Defining the Path Forward, April 26, 2016; USA; 10th IEEE international Conference on Molecular Medicineand Engineering, 17-20 April 2016, Japan; 2ndDrug Delivery Meeting: Advanced Mechanisms & Product Design, May 18-19, 2016, 2016; 6th International Conference on Manipulation, Manufacturing and Measurement on theNanoscale, 18-22 July 2016, China, International Association of Nanotechnology, California, USA, French Society for Nanomedicine, Lille, France, , Asian Nanoscience and Nanotechnology Association, Kagawa, Japan, European Nanoscience and Nanotechnology Association, Bulgaria

Track 12:Nanomedicine and Nanopharmaceuticals

Nanopharmaceuticalssuch as liposomes,quantum dots, dendrimers,carbon nanotubesand polymeric nanoparticles have brought considerable changes in drug delivery and the medical system. Nanopharmaceuticals offer a great benefit for the patients in comparison with the conventional drugs. There are several advantages of these drugs such as enhanced oral bioavailability, improved dose proportionality, enhanced solubility and dissolution rate, suitability for administration and reduced food effects.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

Conference onPharmaceutics March 07-09 2016, Spain; BiosimilarsCongress June 27-29, 2016 Valencia, Spain; Drug DeliverySummit June 30- July 02 2016, USA; Conference onRegulatory Affairs and IPR September 12-14 2016, USA; Asia Pacific MassSpectrometryCongress October 10-12 2016, Malaysia;Advanced MaterialsConference (IC2NAM), January 15th 2016; New Zealand; Modern PhenotypicDrug Discovery: Defining the Path Forward, April 26, 2016; USA; 10th IEEE international Conference on Molecular Medicineand Engineering, 17-20 April 2016, Japan; 2ndDrug Delivery Meeting: Advanced Mechanisms & Product Design, May 18-19, 2016, 2016; 6th International Conference on Manipulation, Manufacturing and Measurement on theNanoscale, 18-22 July 2016, China, International Association of Nanotechnology, California, USA, French Society for Nanomedicine, Lille, France.

Track 13:Nanomedicine and Nanotoxicology

Nanotoxicologyis intended to address the toxicological activities of nanoparticles and their products to determine whether and what extent they may pose a threat to the environment and to human health and defined as the study of the nature and mechanism of toxic effects of nanoscale materials/particles on living organisms and other biological systems. It also deals with the quantitative assessment of the severity and frequency of nanotoxic effects in relation to the exposure of the organisms. The knowledge from nanotoxicology study will be the base for designing safenanomaterialsandnanoproducts,and also direct used innanomedicalsciences.

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting:

Pharmacology andEthnopharmacology Conference May 02-04 2016, USA; Conference on Toxicogenomics June 09-10 2016, USA; Environmental ToxicologySummit August 25-26 2016, Brazil; BiosimilarsCongress September 12-14, 2016 USA; ToxicologySummit October 27-29 2016, Italy;Biosimilarsand Biologics Congress 1-2 February, 2016, Germany; The Oxford ChemicalImmunologyConference, 45 April 2016, United Kingdom; Toxicology and risk assessment conference, April 4-6, 2016; USA; 18th International Conference onBioinformaticsand Bioengineering, April 25-16, 2016, France; Toxicology Meeting, September 47, 2016, Turkey, Society for Personalized Nanomedicine, Florida, USA, European Society for Nanomedicine, Basel, Switzerland

Track 14:Nanomedicine and Nanomedical Devices

Nanomedical devicesshow great promise in various applications for health care. Many nano scale devices have already been approved by the FDA. Nano scale materials can be used as delivery mechanisms allowing cells to absorb therapeutics into the cell wall. Various nano materials are being researched for use in cancer therapeutics.Nanowiresand needles are being researched and developed for use in epilepsy and heart control.Nanosized surgical instrumentscan be used to perform microsurgeriesand better visualization of surgery.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

Generic Drug Market Expo Oct 31- Nov 02 2016, Spain; Medical Devices Expo December 1-3 2016, USA; African Surgical and Medical Devices Expo June 20-21, 2016, South Africa; Conference on Biomaterials March 14-16 2016, UK; Bioavailability & Bioequivalence Summit August 29-31 2016, USA; Microbiology Summit, 2021 January 2016, United Kingdom; 18th International Conference on Biomaterials, Colloids and Nanomedicine, January 21-22, 2016, France; 13th Medical Devices Exhibition & Plastics Disposables, February 12-13, 2016, USA; 18th International Conference on Toxicology, February 25 - 26, 2016; United Kingdom; Faraday Discussion: Nanoparticles with Morphological and Functional Anisotropy, 46 July 2016, United Kingdom, International Association of Nanotechnology, California, USA, French Society for Nanomedicine, Lille, France

Track 15:Nanomedicine and Nanodiagnostics

The use of Nanotechnology in clinical diagnosis is termed asNano diagnostics. Diagnosis at the single cell level or molecular level can be possible through Nano diagnostics. They can even be incorporated even in the current diagnostic methods like Biochips.Nanobiosensorsare promising devices for Clinical applications.

RelatedNanomedicine Conferences|Nano science Meeting |Healthcare Meeting:

Bioavailability and Bioequivalence Summit August 29-31, 2016, USA;Surgical OncologyConference during September 01-03, 2016, Brazil; Precision Medicine ConferenceNovember 03-05, 2016, USA; Translational MedicineConference November 17-19, 2016, USA;Mesothelioma Summit,November 03-04, 2016, Spain; International Conference onBiotechnologyand Nanotechnology, April 14-15, 2016, Portugal;Nanotech Conference & Exhibition, 01-03 June, 2016, France; Materials Scienceand Nanotechnology Conference July 28- 29, 2016, China; 7thInternationalnanotechnology Summit: fundamentals and applications, August 19-10, 2016 Hungary, Society for Personalized Nanomedicine, Florida, USA, European Society for Nanomedicine, Basel, Switzerland.

Track 15:Nanoethics and Regulations

Nanoethicsis the study ethical and social implications of nanotechnologys. It is an emerging but controversial field.Nanoethics is a debatable field.As the research is increasing on nanomedicine, there are certain regulations to increase their efficacy and address the associated safety issues. Other issues in nanoethics include areas likeresearch ethics, environment,global equity, economics, politics, national security, education, life extension and space exploration.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

Generic Drug Market Expo Oct 31- Nov 02 2016, Spain; Medical Devices Expo December 1-3 2016, USA; African Surgical and Medical Devices Expo June 20-21, 2016, South Africa; Conference on Biomaterials March 14-16 2016, UK; Bioavailability & Bioequivalence Summit August 29-31 2016, USA; Microbiology Summit, 2021 January 2016, United Kingdom; 18th International Conference on Biomaterials, Colloids and Nanomedicine, January 21-22, 2016, France; 13th Medical Devices Exhibition & Plastics Disposables, February 12-13, 2016, USA; 18th International Conference on Toxicology, February 25 - 26, 2016; United Kingdom; Faraday Discussion: Nanoparticles with Morphological and Functional Anisotropy, 46 July 2016, United Kingdom, International Association of Nanotechnology, California, USA, French Society for Nanomedicine, Lille, France.

Track 17:Nanomedicine Technologies

Nanomedicine technologiescould find an enhanced position in various areas and applications of the healthcare sector including drug delivery, drug discovery, screening and development, diagnostics and medical devices.BIOMEMSrefers to the application of micro electromechanical systems to micro- and nanosystems for genomics, proteomics, drug-delivery analysis, molecular assembly, tissue engineering, biosensor development, nanoscale imaging, etc.Nanoroboticsrefers to the still largely theoretical nanotechnology engineering discipline of designing and building nanorobots. Different companies are developing novel technologies in Nanomedicine likeNanoTherm therapyandNanobody technology. Nanomedicine in drug discovery is playing a key role in the growing part of pharmaceutical research and development.

RelatedNanomedicine Conferences|Nanotechnology Conferences|Healthcare Meeting:

Pharmacology andEthnopharmacology Conference May 02-04 2016, USA; Conference on Toxicogenomics June 09-10 2016, USA; Environmental ToxicologySummit August 25-26 2016, Brazil; BiosimilarsCongress September 12-14, 2016 USA; ToxicologySummit October 27-29 2016, Italy;Biosimilarsand Biologics Congress 1-2 February, 2016, Germany; The Oxford ChemicalImmunologyConference, 45 April 2016, United Kingdom; Toxicology and risk assessment conference, April 4-6, 2016; USA; 18th International Conference onBioinformaticsand Bioengineering, April 25-16, 2016, France; Toxicology Meeting, September 47, 2016, Turkey, Society for Personalized Nanomedicine, Florida, USA, European Society for Nanomedicine, Basel, Switzerland.

Conference Series LLCinvites the contributors across the globe to participate in the premier International Conference on Nanomedicine and Nanotechnology in Health Care (Nanomedicine-2016), to discuss the theme: "Nanomedicine: The Remarkable Technology Thats Changing the Face of Healthcare The conference will be held at Avani Atrium, Bangkok, Thailand during July 25-27,2016.

Conference Series Llc organizes a conference series of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members

International Conference on Nanomedicine and Nanotechnology in Health Care (Nanomedicine 2016) aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of Nanomedicine in Healthcare. It also provides the premier interdisciplinary forum for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Nanomedicine. The conference program will cover a wide variety of topics relevant to the nanomedicine, including: nanomedicine in drug discover and delivery, nanodiagnostics, theranostics, applications of nanomedine in healthcare applications and disease treatments.

Why to attend?

With members from around the world focused on learning about nanomedicine and its advances; this is your best opportunity to reach the largest assemblage of participants from the Nanotechnology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event.

Target Audience:

Nanomedicine Academia Professors , Medical professionals, Nanomedicine Department heads, Nanomedicine researchers, Nanomedicine CTOs, Nanomedicine product managers, business development managers, Entrepreneurs, Industry analysts, Investors, Students, Media representatives and decision makers from all corners of Nanoscience research area around the globe.

We therefore encourage all colleagues from all over the world to participate and help us to make this an unforgettable important and enjoyable meeting.

We look forward to seeing you in Bangkok, Thailand !!!

For more

10th International conference on Nanomedince and Nantotechnology in Healthcare

July 25-27, 2016 Bangkok, Thailand

Summary of Nanomedicine Conference:

Nanomedicine 2016 welcomes attendees, presenters, and exhibitors from all over the world to Bangkok, Thailand. We are delighted to invite you all to attend and register for the 10th International conference and exhibition on Nanomedicine and Nanotechnology in Healthcare which is going to be held during July 25-27, 2016 at Bangkok, Thailand. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Nanomedicine-2016, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Nanomedicine 2016 organizing committee look forward to meet in person.

Scope and Importance:

The emergence of nanomedicine and the application of nanomaterials in the healthcare industry will bring about groundbreaking improvements to the current therapeutic and diagnostic scenario. Some of the drivers of this market include increasing research funding, rising government support, improved regulatory framework, technological know-how and rising prevalence of chronic diseases such as diabetes, cancers, obesity, kidney disorders, orthopedic diseases and others.

Market Analysis:

In the past few years, the global nanomedicine market has witnessed an increasing use of novel nanomaterials and emergence of nanorobotics on a global front. The market has also observed a significant demand for personalized medicines due to its ability to treat patients based on customized treatments and other medical and genetic conditions.

Overall research in various disciplines:

The North American nanomedicine market held the majority of global market share in 2012 because of the rapidly growing nanomedicine market in the Asia-Pacific, Latin American and African region, presence of large number of patented nanomedicine products and favorable regulatory framework in the region. In addition, the presence of sophisticated healthcare infrastructure supports development of advanced products such as nano probes, nanorobots, monoclonal antibody based immunoassays and nanoparticle based imaging agents for early detection of diseases.

However, the Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in nanomedicine research funding in emerging economies such as China, India and other economies in the region. China is expected to surpass the United States in terms of nanotechnology funding in the near future, which indicates the growth offered by this region.

Nanomedicine study in various countries:

Companies involved in Nanomedicine:

GE Healthcare, Mallinckrodt plc, Nanosphere Inc., Pfizer Inc., Merck & Co Inc., Celgene Corporation, CombiMatrix Corporation, Abbott Laboratories are some of the major companies in the Nanomedicine market.

Why Bangkok, Thailand?

Bangkok is the cultural, economic and political capital of Thailand. The city features both old-world charm and modern convenience. Many visitors in Bangkok are overwhelmed by the sheer size of the city and the vast number of attractions it has to offer. Indeed, there are many sightseeing opportunities in Bangkok, spanning for more than two centuries of rapid development following the citys founding in 1782. As Bangkok is considered a transport hub and a popular travel destination in Asia, we believe it would be beneficial to all the delegates who are attending the conference.

At present the research on nanomedicine is currently less due to the unavailability of funds and lack of proper expertise. The Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in nanomedicine research funding in emerging economies such as China, India and other economies in the region. China is expected to surpass the United States.

Conference Highlights:

Continue reading here:
Nanomedicine Conferences| Nanotechnology conferences| 2016 ...

Pharmacogenomics – Official Site

This site uses cookies to improve performance. If your browser does not accept cookies, you cannot view this site.

There are many reasons why a cookie could not be set correctly. Below are the most common reasons:

This site uses cookies to improve performance by remembering that you are logged in when you go from page to page. To provide access without cookies would require the site to create a new session for every page you visit, which slows the system down to an unacceptable level.

This site stores nothing other than an automatically generated session ID in the cookie; no other information is captured.

In general, only the information that you provide, or the choices you make while visiting a web site, can be stored in a cookie. For example, the site cannot determine your email name unless you choose to type it. Allowing a website to create a cookie does not give that or any other site access to the rest of your computer, and only the site that created the cookie can read it.

Continued here:
Pharmacogenomics - Official Site

Albert Einstein College of Medicine – Wikipedia, the free …

Coordinates: 405103N 735042W / 40.850852N 73.844949W / 40.850852; -73.844949

The Albert Einstein College of Medicine ("Einstein"), a part of Montefiore Medical Center, is a not-for-profit, private, nonsectarian medical school located in the Morris Park neighborhood of the Bronx in New York City. In addition to M.D. degrees, Einstein offers graduate biomedical degrees through its Sue Golding Graduate Division. Allen M. Spiegel, M.D., has served as The Marilyn and Stanley M. Katz Dean since June 1, 2006.[1]

Einsteins areas of focus are medical education, basic research, and clinical research. The school is well known for its humanistic approach to medicine and the diversity of its student body. The class of 2019 includes 183 students from 23 different states. In addition, 18% were born outside the U.S., and 12% identify themselves as belonging to groups considered underrepresented in medicine.[2]

Einstein is a major biomedical and clinical research facility. Faculty members received $157 million in research grants from the National Institutes of Health in 2014, ranking 25th out of 138 medical schools in the U.S. The N.I.H. funding includes major amounts for research in aging, disorders of intellectual development, diabetes, cancer, liver disease, and AIDS.[3]

Dr. Samuel Belkin president of Yeshiva University, began planning a new medical school as early as 1945. Six years later, Dr. Belkin and New York City Mayor Vincent Impellitteri entered into an agreement to begin its construction. Around the same time, world-renowned physicist and humanitarian Albert Einstein sent a letter to Dr. Belkin. He remarked that such an endeavor would be "unique" in that the school would "welcome students of all creeds and races".[4] Two years later, on his 74th birthday, March 14, 1953, Albert Einstein agreed to have his name attached to the medical school.

The first classes began September 12, 1955, with 56 students. It was the first new medical school to open in New York City since 1897. The Sue Golding Graduate Division was established in 1957 to offer Ph.D. degrees in biomedical disciplines.[5] The Medical Scientist Training Program, a combined M.D.-Ph.D. program, was started 1964.[6] The Clinical Research Training Program, which confers M.S. degrees in clinical research methods, began in July 1998.[7]

Einstein has been the site of major medical achievements and accomplishments, including:[8]

The College of Medicine has been the center of several allegations of discrimination. In 1994, Einstein was sued by Heidi Weissmann, a researcher in nuclear medicine and former associate professor of radiology, for sexual discrimination for not promoting her due to gender bias. The case was settled for $900,000.[9] In 1998, Yeshiva University and Einstein were sued by the American Civil Liberties Union for discrimination of two medical students over their sexual orientation by not allowing their non-student, non-married partners to live with them in student housing.[10]

In February 2015, Yeshiva University announced the transfer of ownership of Einstein to the Montefiore Health System, to eliminate a large deficit from the university's financial statements. The medical school accounted for approximately two-thirds of the university's annual operating deficits, which had reached about $100 million before the announcement.[11] On September 9, 2015, the agreement between Yeshiva and Montefiore was finalized, and financial and operational control of Albert Einstein College of Medicine was transferred to Montefiore.[12] Yeshiva University plans to continue to grant Einstein's degrees until 2018, when Einstein's application for its own degree-granting authority is expected to be approved.[13]

The school offers M.D. and Ph.D. degrees and has a Medical Scientist Training Program that gives combined M.D.-Ph.D. degrees. Students pursuing Ph.D. or M.D.-Ph.D. degrees get full tuition remission and a stipend of $33,000.[23] Einstein also offers M.S. degrees in clinical research methods and in bioethics. The school is well known for promoting community medical awareness, and for humanism in social, ethical, and medical realms through its hospital affiliations, free Einstein Community Health Outreach clinic, and Bronx community health fairs.

It is currently ranked #39 in research by U.S. News & World Report out of 153 medical schools.[24] A study published by researchers at Harvard Medical School and the University of California, San Francisco, which sought to eliminate the subjective metrics present in the U.S. News and World Report rankings, gave a rank of #13 to Einstein relative to other schools in the United States, placing it among the nation's top 10 percent of medical schools. [25][26]

The Albert Einstein College of Medicine is affiliated with five medical centers: Montefiore Medical Center, [27] the University Hospital and academic medical center for Einstein; Jacobi Medical Center, Einsteins founding hospital and first affiliate, and three other hospital systems: Bronx Lebanon Hospital, North Shore-LIJ Health System on Long Island, and Maimonides Medical Center in Brooklyn. Through its affiliation network, Einstein runs the largest postgraduate medical training program in the U.S.

Einstein runs the Rose F. Kennedy Center, which conducts research and treatment for people with developmental disabilities.

Einstein has many departments in various fields of academic medicine and basic science. Ph.D. and M.D.-Ph.D. degrees are offered in:[28]

The Einstein Campus is named for Jack and Pearl Resnick. Its main features are:

The Rose F. Kennedy Center for Research in Mental Retardation and Human Development is on the adjacent campus of Jacobi Medical Center. The Rhinelander Hall Residence Complex, several blocks away on Rhinelander Avenue, houses post-doctoral fellows and medical students.

Einstein is located in Morris Park, a residential neighborhood in the northeast Bronx, several miles from Manhattan. The Wildlife Conservation Park, better known as the Bronx Zoo, and the New York Botanical Garden and its Enid Haupt Conservatory are nearby. The fishing community of City Island, which features marinas and a broad selection of seafood restaurants is also a short distance away.[45]

There are more than 50 student clubs organized around a variety of activities, medical specialties, and a wide range of religious, political, and ethnic affiliations. Offerings include dance and movie clubs, an arts and literary magazine, and the Einstein Community Health Outreach, which launched New York States first student-coordinated free clinic.[46]

Read more:
Albert Einstein College of Medicine - Wikipedia, the free ...

The Lancet Neurology – ScienceDirect.com

Volume 15, Issue 6 - selected pp. 533-648 (May 2016)

Issue contains Open Access articles

Not entitled to full text

Not entitled to full text

Issue contains Open Access articles

Issue contains Open Access articles

Issue contains Open Access articles

Not entitled to full text

Issue contains Open Access articles

Not entitled to full text

Issue contains Open Access articles

Not entitled to full text

Issue contains Open Access articles

Not entitled to full text

Issue contains Open Access articles

Issue contains Open Access articles

Issue contains Open Access articles

Not entitled to full text

Issue contains Open Access articles

Issue contains Open Access articles

Not entitled to full text

Not entitled to full text

Issue contains Open Access articles

Issue contains Open Access articles

Not entitled to full text

Not entitled to full text

Not entitled to full text

Issue contains Open Access articles

Issue contains Open Access articles

Not entitled to full text

Issue contains Open Access articles

Not entitled to full text

Not entitled to full text

Not entitled to full text

Issue contains Open Access articles

Issue contains Open Access articles

Not entitled to full text

Issue contains Open Access articles

Issue contains Open Access articles

Issue contains Open Access articles

Issue contains Open Access articles

Not entitled to full text

Issue contains Open Access articles

Not entitled to full text

Issue contains Open Access articles

Issue contains Open Access articles

Issue contains Open Access articles

Issue contains Open Access articles

Not entitled to full text

Issue contains Open Access articles

Not entitled to full text

Issue contains Open Access articles

Issue contains Open Access articles

Issue contains Open Access articles

Not entitled to full text

View post:
The Lancet Neurology - ScienceDirect.com

Wellington Hospital :: Neurology

Stroke and transient ischaemic attack (TIA)

A stroke occurs when the blood supply to part of the brain is interrupted by a blockage in the blood supply or when there is a haemorrhage due to a burst blood vessel. A patient will complain of weakness in an arm and or leg, difficulty with speech and /or language, lost vision in part of the visual field or complain of numbness and/ or tingling down one side of the body. If the blood supply is interrupted for a short time only, the brain cells may recover function this is a transient attack (TIA). It is vital to seek urgent medical opinion when these events occur.

Approximately 1 - 2 people per 1000 have strokes each year in the UK.

In patients who have suffered a TIA, the risk of a full blown stroke is high and an urgent assessment needs to be carried out by a neurologist to try and prevent this from happening. Investigations will include a brain scan ; carotid dopplers - which study the main carotid arteries supplying the brain, in case there is a severe narrowing that may be amenable to treatment by surgery (carotid endarterectomy or stenting); cardiac (heart) assessment; and blood tests. In patients who have already suffered a stroke, there are treatments now available (thrombolysis) which, if given quickly enough to appropriate patients, may prevent further damage.

This is a common cause of headache with 10% of the population being affected with different levels of severity. The other common causes of headache are muscle tension or cervicogenic headache and headache due to overuse of painkillers.

Migraine is a headache characterised by a one sided throbbing headache with associated nausea and vomiting, sensitivity to light (photophobia), noise (phonophobia) and/or smells (osmophobia). The underlying mechanism is believed to be due abnormal wiring within the brain. The disorder often runs in families.

Migraine attacks may be triggered by a variety of causes including stress or even relief after a period of stress, lack of or too much sleep, certain foods such as cheese, red wine and chocolate. Each sufferer will be able to identify differing triggers some are unusual, such as a change in barometric pressure or a specific perfume!

Although migraine is not life threatening, it causes a great deal of distress and suffering both in those afflicted and in their families.

Treatments are available in the form of medication for acute attacks. In those who suffer with frequent attacks, medication is available for the prevention of the migraine attacks (prophylaxis).

Epilepsy is diagnosed when a person has had two or more seizures. Approximately 1 in 200 adults suffer with this condition. Epilepsy may be caused by a variety of conditions including head injury, brain tumours, and stroke or after a brain infection such as meningitis or encephalitis. In some patients, epilepsy may run in families or no cause is identified. Anyone who has suffered with a seizure needs to see a neurologist for an assessment. Epilepsy can be managed by drug treatment, usually under the supervision of a neurologist.

MS is an inflammatory condition that affects the brain and spinal cord, the so-called central nervous system. This may occur in attacks with some or complete recovery between attacks (relapsing /remitting), or it may be progressive, with patients slowly getting worse.

The disease increases in frequency the further one moves away form the equator and is therefore more common in colder climates, with the highest frequency in the North of Scotland. In the UK, about 60 per 100,000 people are affected. It is more common in females.

The underlying cause is unknown but it is believed that a person may be genetically susceptible to the disease that may be triggered by an unknown virus.

Patients who have suffered an attack with, for example, weakness of the arm and/or legs, tingling in the limbs, double vision or unsteadiness and inco-ordination, need to be seen by a neurologist. Investigations that may be necessary include a MRI scan, visual evoked responses (which are neurophysiological tests studying the pathway of vision from the eyes to the brain), and perhaps a lumbar puncture test.

Treatment for an acute attack may be with steroids given into the vein (intravenously). Treatment with disease modifying drugs (DMD) such as interferons and copolymer 1. can now reduce the number of relapses. Physiotherapy is an important aspect in the management of any patient with MS.

PD is due to the loss of certain nerve cells within that part of the brain that controls movement (basal ganglia). Patients may present with some or all of the following slowness of movement, stiffness, tremor and instability. There are differing causes of Parkinsonism of which PD is one cause others include multiple small strokes; certain drugs such as those used in psychiatric disorders; dizziness or nausea and vomiting for long periods; rarer conditions such as multiple system atrophy and progressive supranuclear palsy (PSP); and repeated head injuries as may occur in boxers.

PD occurs in about 1 in 1000 rising to 5 in 1000 after the age of 70 years. In the UK, at any one time there are about 100,000 sufferers.

Although there are no specific tests for PD, it is necessary to be seen by a neurologist to make the diagnosis and also to exclude other causes.

There is no cure for PD but there are good treatments in the form of tablets that will help alleviate the symptoms of tremor and slowness. There are also surgical options in patients who are suitable.

Dementia is a condition which reflects a decline in mental ability due to nerve cell loss in different parts of the brain. Patients or their relatives may complain of memory loss, impaired reasoning or judgement, changes in mood, behaviour and personality.

The most common cause of dementia in the UK is Alzheimer's disease. Other causes include multiple strokes, fronto-temporal dementia (another degenerative condition of the brain) and diffuse cortical Lewy body disease where patients may also have Parkinsonism.

Dementia usually affects older people approximately 5% in those over the age of 65 years and 20% of those over the age of 80 years.

Any patient suspected of having dementia should see a neurologist who will try and exclude other reversible causes such as depression, vitamin deficiencies, thyroid disease, brain infections and rarely tumours. Investigations carried out may include blood tests, brain scan (MRI or CT scan), EEG, a neurocognitive assessment where memory and other brain functions can be assessed by a neuropsychologist with special tests that are a little like IQ tests.

There is no cure for Alzheimer's disease but there are treatments available that may help to slow down the progression of the disease by a few months.

Read more from the original source:
Wellington Hospital :: Neurology

Immortality – The Atheist; scourge of religion and scammers

As of January 2016, the site has been accessed hundreds of thousands of times by people searching for facts about fuel-saving scams and psychics' claims from Sensing Murder in particular. We have added another fuel scam - Fuel360. Read all about it here.

We have had feedback from people all over the world who have learned that fuel-saving devices don't work, saving them thousands of dollars in wasted payments to scammers.

Have a look around, and if you want to ask a question, or get us to investigate a scam, email alan@immortality.co.nz and we'll get right on the case!

While I love to take on all scams and blatant bullshit, I am The Atheist, and my prime target is the stupidity, delusion and bullshit that make up the world's religions.

In the year 2016, when science can attempt to create a mini "big bang" at CERN, can replace almost every organ in the human body with a high degree of success, and can cure cancers that were deadly only a generation ago, we live in times where rationality and reason should take precedence over everything else.

Alas, that is not so, and as time marches on, religion is strengthening its hold on more and more people.

Many atheists rejoice in censuses showing decline in the "religion" identifier question, but I believe that is false hope, as the number of people who attend church has risen dramatically over the past decade. 40 years ago, almost no people aged between 18 and 40 went to church, nowadays, they have overflowing carparks.

The impact of these increased numbers - and therefore money and power - is easy to see if you know where to look. From Family First to the Maxim Institute, religions have set up fronts as "family-focused" organisations as pressure groups, and because they're funded by morons giving 10% of their wedge every week, they ensure they're heard, with an array of fulltime workers and ring-in "experts".

Look at the thousands of people who have protested recently against homosexual & marital laws and non-smacking of children. "Spare the rod and you'll spoil the child" the bible tells the religionistas and they believe it. You can bet that every single protestor against anti-smacking laws was a theist of some description or other. (update August 2012 - note the current massive spending campaign by Family First against proposals to allow people of all genders to marry)

I will not stand by and watch these deluded wankers have it all their own way.

Some - especially agnostics - people cry about "evangelical" or militant atheism as though it were a bad thing.

I say that without the soldiers of atheism being in the faces of religion, they would seek to destroy more than they already have. USA is a prime example, where even 87 years after the Scopes monkey trial, religion is trying to take over school curricula and replace science with mythology.

Other reading on the subject includes this article from Huffington Post, the best part of which is not the idiotic, unreferenced and unresearched article itself, but the comments that follow it and give the true picture of atheism and religion in USA.

The idea that "new" atheism is unnecessary or overdone is just more romantic bullshit from the promoters and apologists for religion.

If you follow the kind of religion like the Anglican Church promotes, I have no beef with you. If you find that the delusion of god makes you happy, then I'm happy. It's only when you try to impose your will on others I get pissed off.

But if you're the kind of religionista who feels that the world must conform to your delusion of a sky-daddy, then the only thing which separates you from islamist extremist with AK47s is that you're living in the privileged western world. As Jesus Camp showed us, even allegedly christian religions have elements of extremism every bit as spiteful and abusive as the worst excesses of Wahabiism.

I cringe at people whose delusions are so powerful they would rather watch someone die in agony rather than allow to die with dignity.

You can bet your last buck that the same cruel theist who would deny euthanasia for a human will be off to the vet to euthanase a loved pet rather than watch it suffer a lingering, painful death.

Double standards. Love 'em.

And for the best help you can find for employment disputes, seven of the best!

onetwothree four five sixseven

View post:
Immortality - The Atheist; scourge of religion and scammers

IRM at UPenn – Institute For Regenerative Medicine – Phila

The Institute for Regenerative Medicine is based in the Smilow Center for Translational Research and extends across UPenns campus.

The links between medicine, engineering and veterinary science differentiate Penns Institute for Regenerative Medicine from other stem cell Institutes across the country.

The IRM promotes discoveries in stem cell biology and regeneration to generate new therapies that may alleviate suffering and disease.

When our interdisciplinary research and programs bring together individuals with broad interests and diverse backgrounds, our collaborations lead to greater advances.

Stem cell research is critical to developing new skin tissues and, ultimately, changing the way we care for devastating wounds.

At Penn, we're discovering real possibilities of future treatments for cardiac disease because we have the research and clinical expertise to make it happen.

Thursday - April 21, 2016

Finding could lead to better drugs for the many asthma patients who dont respond well to current medications PHILADELPHIAAsthma is an enormous public health problem that continues to grow larger, in part because scientists dont

Read More...

Wednesday - March 23, 2016

This spring, the BioEYES program celebrates a major milestone: It will serve its 100,000th student. That means in the 14 years since BioEYES began, 100,000 elementary, middle, and high school students from Philadelphia and four

Read More...

Wednesday - February 10, 2016

A study from researchers at The Childrens Hospital of Philadelphia may add new lines to the textbook description of how cancer cells divide uncontrollably and develop into tumors. Their study, published in Nature Communications, identifies

Read More...

Follow this link:
IRM at UPenn - Institute For Regenerative Medicine - Phila

Erie Community College :: Nanotechnology

The Nanotechnology AAS degree program is designed to help prepare students from a broad range of disciplines for careers in fields involving Nanotechnology. Nanotechnology is engineering at theatomiclength scale, a size range which until recently was only available to nature. Being able to engineer such small structures opens the door to a multitude of new opportunities in the fields of electronic and semiconductor fabrication technology, micro-technology labs, material science labs, chemical technology, biotechnology, biopharmaceutical technology, and environmental science.

Students will study electronic device and circuit behavior, basic chemistry and fabrication techniques used to create micron and submicron scale structures. Techniques covered include reactive ion etching, metallization, thick and thin film deposition and photolithography.

Graduates will enter the job market with the skills necessary for positions in the following areas:

Upon graduation with an Associate in Applied Science degree in Nanotechnology, the graduate will be qualified in working with the following items and their associated tasks:

Total Degree Credits: 63.0

First Year, Fall Semester NS 100 - Introduction to Nanotechnology Credit Hours: 3 BI 110 - Biology I Credit Hours: 3 BI 115 - Laboratory for BI 110 Credit Hours: 1.5 EL 118 - Electrical Circuits I Credit Hours: 2 EN 110 - College Composition Credit Hours: 3 MT 125 - College Mathematics Credit Hours: 4

First Year, Spring Semester CH 180 - University Chemistry I Credit Hours: 3 CH 181 - Lab for CH 180 Credit Hours: 1.5 MT 126 - College Mathematics II Credit Hours: 4 PH 270 - College Physics I Credit Hours: 4.5 PH 271 - Lab for PH 270 Credit Hours: (Included in the 4.5 credit hours for PH 270) Social Science or Humanities Elective Credit Hours: 3

Second Year, Fall Semester NS 201 - Materials, Safety and Equipment Overview for Nanotechnology Credit Hours: 3 EL 158 - Electrical Circuits II Credit Hours: 3 EL 159 - Lab for EL 158 Credit Hours: 1 PH 272 - College Physics II Credit Hours: 4.5 PH 273 - Lab for PH 272 Credit Hours: (Included in the 4.5 credit hours for PH 272) Approved Elective Credit Hours: 4*

Second Year, Spring Semester NS 202 - Basic Nanotechnology Processes Credit Hours: 3 NS 203 - Characterization of Nanotechnology Structures and Materials Credit Hours: 3 NS 204 - Materials in Nanotechnology Credit Hours: 3 NS 205 - Patterning for Nanotechnology Credit Hours: 3 NS 206 - Vacuum Systems and Nanotechnology Applications Credit Hours: 3

*Approved Electives: BI 230/231 Microbiology and Lab (4 credits); CH 182/183 University Chemistry II and Lab (4.5 credits); EL 154/155 Electronics I and Lab (4 credits); IT 126 Statistical Process Control (3 credits) and IT 210 Industrial Inspection/Metrology(2 credits); MT 143 Introductory Statistics I (4 credits); MT 180 Pre-Calculus Mathematics (4 credits)

Continued here:
Erie Community College :: Nanotechnology

What is nanotechnology? | HowStuffWorks

During the Middle Ages, philosophers attempted to transmute base materials into gold in a process called alchemy. While their efforts proved fruitless, the pseudoscience alchemy paved the way to the real science of chemistry. Through chemistry, we learned more about the world around us, including the fact that all matter is composed of atoms. The types of atoms and the way those atoms join together determines a substance's properties.

Nanotechnology is a multidisciplinary science that looks at how we can manipulate matter at the molecular and atomic level. To do this, we must work on the nanoscale -- a scale so small that we can't see it with a light microscope. In fact, one nanometer is just one-billionth of a meter in size. Atoms are smaller still. It's difficult to quantify an atom's size -- they don't tend to hold a particular shape. But in general, a typical atom is about one-tenth of a nanometer in diameter.

But the nanoscale is where it's at. That's because it's the scale of molecules. By manipulating molecules, we can make all sorts of interesting materials. But like the alchemists of old, we wouldn't make much headway in creating gold. That's because gold is a basic element -- you can't break it down into a simpler form.

We could make other interesting substances, though. By manipulating molecules to form in particular shapes, we can build materials with amazing properties. One example is a carbon nanotube. To create a carbon nanotube, you start with a sheet of graphite molecules, which you roll up into a tube. The orientation of the molecules determines the nanotube's properties. For example, you could end up with a conductor or a semiconductor. Rolled the right way, the carbon nanotube will be hundreds of times stronger than steel but only one-sixth the weight [source: NASA].

That's just one aspect of nanotechnology. Another is that materials aren't the same at the nanoscale as they are at larger scales. Researchers with the United States Department of Energy discovered in 2005 that gold shines differently at the nanoscale than it does in bulk. They also noticed that materials possess different properties of magnetism and temperature at the nanoscale [source: U.S. Department of Energy].

Because the science deals with the basic building blocks of matter, there are countless applications. Some seem almost mundane -- nanoparticles of zinc oxide in sunblock allow you to spread a transparent lotion on your skin and remain protected. Others sound like science fiction -- doctors are attempting to use the protein casings from viruses to deliver minute amounts of drugs to treat cancer. As we learn more about how molecules work and how to manipulate them, we'll change the world. The biggest revelations will come from the smallest of sources.

Learn more about nanotechnology by following the links on the next page.

Read more:
What is nanotechnology? | HowStuffWorks

The Ethics of Nanotechnology – Santa Clara University

Introduction

Imagine a world in which cars can be assembled molecule-by-molecule, garbage can be disassembled and turned into beef steaks, and people can be operated on and healed by cell-sized robots. Sound like science fiction? Well, with current semiconductor chip manufacturing encroaching upon the nanometer scale and the ability to move individual atoms at the IBM Almaden laboratory, we are fast approaching the technological ability to fabricate productive machines and devices that can manipulate things at the atomic level. From this ability we will be able to develop molecular-sized computers and robots, which would give us unprecedented control over matter and the ability to shape the physical world as we see fit. Some may see it as pure fantasy, but others speculate that it is an inevitability that will be the beginning of the next technological revolution.

Laboratories, such as the Stanford Nanofabrication Facility (SNF), have already been researching nanofabrication techniques with applications in fiber optics, biotechnology, microelectromechanical systems (MEMS), and wide variety of other research fields relevant to today's technology. MEMS, "tiny mechanical devices such as sensors, valves, gears, mirrors, and actuators embedded in semiconductor chips", are particularly interesting because they are but a mere step away from the molecular machines envisioned by nanotechnology. MEMS are already being used in automobile airbag systems as accelerometers to detect collisions and will become an increasing part of our everyday technology.

In 1986, a researcher from MIT named K. Eric Drexler already foresaw the advent of molecular machines and published a book, Engines of Creation, in which he outlined the possibilities and consequences of this emerging field, which he called nanotechnology. He was inspired by Nobel laureate Richard Feynman's 1959 lecture, There's Plenty of Room at the Bottom, about miniaturization down to the atomic scale. Since then, Drexler has written numerous other books on the subject, such as Unbounding the Future, and has founded the Foresight Institute, which is a nonprofit organization dedicated to the responsible development of nanotechnology. It hosts conferences and competitions to raise the awareness of nanotechnology and the ethical issues involved in its development.

Today, nanotechnology research and development is quite wide spread, although not high profile yet. Numerous universities, such as Univ. of Washington and Northwestern Univ., have established centers and institutes to study nanotechnology, and the U.S. government has created an organization, the National Nanotechnology Initiative (NNI), to monitor and guide research and development in this field. In fact, as noted in an April 2001 Computerworld article, the Bush administration increased funding to nanoscale science research by 16% through its National Science Foundation (NSF) budget increase. DARPA (Defense Advanced Research Projects Agency) and the NSF are currently the two largest sources of funding for nanotechnology research and have an enormous influence on the direction of scientific research done in the United States. With so many resources dedicated to its development, nanotechnology will surely have an impact within our lifetime, so it is important to examine its ethical implications while it is still in its infancy.

What is Nanotechnology?

Nanotechnology, also called molecular manufacturing, is "a branch of engineering that deals with the design and manufacture of extremely small electronic circuits and mechanical devices built at the molecular level of matter." [Whatis.com] The goal of nanotechnology is to be able to manipulate materials at the atomic level to build the smallest possible electromechanical devices, given the physical limitations of matter. Much of the mechanical systems we know how to build will be transferred to the molecular level as some atomic analogy. (see nanogear animation on the right)

As envisioned by Drexler, as well as many others, this would lead to nanocomputers no bigger than bacteria and nanomachines, also known as nanites (from Star Trek: The Next Generation), which could be used as a molecular assemblers and disassemblers to build, repair, or tear down any physical or biological objects.

In essence, the purpose of developing nanotechnology is to have tools to work on the molecular level analogous to the tools we have at the macroworld level. Like the robots we use to build cars and the construction equipment we use to build skyscrapers, nanomachines will enable us to create a plethora of goods and increase our engineering abilities to the limits of the physical world.

Potential Benefits...

It would not take much of a leap, then, to imagine disassemblers dismantling garbage to be recycled at the molecular level, and then given to assemblers for them to build atomically perfect engines. Stretching this vision a bit, you can imagine a Star Trek type replicator which could reassemble matter in the form of a juicy steak, given the correct blueprints and organization of these nanomachines.

Just given the basic premises of nanotechnology, you can imagine the vast potential of this technology. Some of it's more prominent benefits would be:

Along with all the obvious manufacturing benefits, there are also many potential medical and environmental benefits. With nanomachines, we could better design and synthesize pharmaceuticals; we could directly treat diseased cells like cancer; we could better monitor the life signs of a patient; or we could use nanomachines to make microscopic repairs in hard-to-operate-on areas of the body. With regard to the environment, we could use nanomachines to clean up toxins or oil spills, recycle all garbage, and eliminate landfills, thus reducing our natural resource consumption.

Potential Dangers...

The flip side to these benefits is the possibility of assemblers and disassemblers being used to create weapons, be used as weapons themselves, or for them to run wild and wreak havoc. Other, less invasive, but equally perilous uses of nanotechnology would be in electronic surveillance.

Weapons are an obvious negative use of nanotechnology. Simply extending today's weapon capabilities by miniaturizing guns, explosives, and electronic components of missiles would be deadly enough. However, with nanotechnology, armies could also develop disassemblers to attack physical structures or even biological organism at the molecular level. A similar hazard would be if general purpose disassemblers got loose in the environment and started disassembling every molecule they encountered. This is known as "The Gray Goo Scenario." Furthermore, if nanomachines were created to be self replicating and there were a problem with their limiting mechanism, they would multiply endlessly like viruses. Even without considering the extreme disaster scenarios of nanotechnology, we can find plenty of potentially harmful uses for it. It could be used to erode our freedom and privacy; people could use molecular sized microphones, cameras, and homing beacons to monitor and track others.

Ethical Issues & Analysis

With such awesome potential dangers inherent in nanotechnology, we must seriously examine its potential consequences. Granted, nanotechnology may never become as powerful and prolific as envisioned by its evangelists, but as with any potential, near-horizon technology, we should go through the exercise of formulating solutions to potential ethical issues before the technology is irreversibly adopted by society. We must examine the ethics of developing nanotechnology and create policies that will aid in its development so as to eliminate or at least minimize its damaging effects on society.

Ethical Decision Making Worksheet

Most relevant facts

We are reaching a critical point where technology will enable us to build complex molecular machines. Molecular assemblers and disassemblers could be developed from this technology, which would have great potential for both good and bad. The two greatest threats from development of nanotechnology are catastrophic accidents and misuse.

Professional Issues

Legal/Policy Issues

Ethical Issues

Stakeholders

Possible Actions

Consequences

Individual Rights/Fairness

The second and third options seem to be the most prudent course of action since the second option is commonly done now for emerging technologies and the third option consciously prevents designs that could lead to the catastrophic scenarios.

Common Good

The second and third options also seem to advance the most common good since the second option involves promoting ethics within the research community and the third option is a set of design principles to discourage unethical or accidental uses of nanotechnology.

Final Decision

Nanotechnology research should be allowed to continue but with a non-government advisory council to monitor the research and help formulate ethical guidelines and policies. Generally, nanomachines should NOT be designed to be general purpose, self replicating, or to be able to use an abundant natural compound as fuel. Furthermore, complex nanomachines should be tagged with a radioactive isotope so as to allow them to be tracked in case they are lost.

Conclusion

It would be difficult to deny the potential benefits of nanotechnology and stop development of research related to it since it has already begun to penetrate many different fields of research. However, nanotechnology can be developed using guidelines to insure that the technology does not become too potentially harmful. As with any new technology, it is impossible to stop every well funded organization who may seek to develop the technology for harmful purposes. However, if the researchers in this field put together an ethical set of guidelines (e.g. Molecular Nanotechnology Guidelines) and follow them, then we should be able to develop nanotechnology safely while still reaping its promised benefits.

References

Drexler, K. Eric Engines of Creation. New York: Anchor Books, 1986.

Drexler, K. Eric Unbounding the Future. New York: Quill, 1991.

Feynman, Richard P. There's Plenty of Room at the Bottom. 03 March 2002. http://www.zyvex.com/nanotech/feynman.html

The Foresight Institute. 03 March 2002. http://www.foresight.org/

Institute for Molecular Manufacturing. 03 March 2002. IMM.org

National Nanotechnology Initiative. 03 March 2002. http://www.nano.gov/

Thibodeau, Patrick. "Nanotech, IT research given boost in Bush budget". 03 March 2002. (April 11, 2001) CNN.com

[Definitions]. 03 March 2002. Whatis.com

Read the original post:
The Ethics of Nanotechnology - Santa Clara University

Nanotechnology – Centers for Disease Control and Prevention

Nanotechnology is the manipulation of matter on a near-atomic scale to produce new structures, materials and devices. The technology promises scientific advancement in many sectors such as medicine, consumer products, energy, materials and manufacturing. Nanotechnology is generally defined as engineered structures, devices, and systems. Nanomaterials are defined as those things that have a length scale between 1 and 100 nanometers. At this size, materials begin to exhibit unique properties that affect physical, chemical, and biological behavior. Researching, developing, and utilizing these properties is at the heart of new technology.

Workers within nanotechnology-related industries have the potential to be exposed to uniquely engineered materials with novel sizes, shapes, and physical and chemical properties. Occupational health risks associated with manufacturing and using nanomaterials are not yet clearly understood. Minimal information is currently available on dominant exposure routes, potential exposure levels, and material toxicity of nanomaterials.

Studies have indicated that low solubility nanoparticles are more toxic than larger particles on a mass for mass basis. There are strong indications that particle surface area and surface chemistry are responsible for observed responses in cell cultures and animals. Studies suggests that some nanoparticles can move from the respiratory system to other organs. Research is continuing to understand how these unique properties may lead to specific health effects.

NIOSH leads the federal government nanotechnology initiative. Research and activities are coordinated through the NIOSH Nanotechnology Research Center (NTRC) established in 2004.

Read more from the original source:
Nanotechnology - Centers for Disease Control and Prevention

Learn About Nanotechnology in Cancer

Nanotechnologythe science and engineering of controlling matter, at the molecular scale, to create devices with novel chemical, physical and/or biological propertieshas the potential to radically change how we diagnose and treat cancer. Although scientists and engineers have only recently (ca. 1980's) developed the ability to industrialize technologies at this scale, there has been good progress in translating nano-based cancer therapies and diagnostics into the clinic and many more are in development.

Nanoscale objectstypically, although not exclusively, with dimensions smaller than 100 nanometerscan be useful by themselves or as part of larger devices containing multiple nanoscale objects. Nanotechnology is being applied to almost every field imaginable including biosciences, electronics, magnetics, optics, information technology, and materials development, all of which have an impact on biomedicine. Explore the world of nanotechnology

Nanotechnology can provide rapid and sensitive detection of cancer-related targets, enabling scientists to detect molecular changes even when they occur only in a small percentage of cells. Nanotechnology also has the potential to generate unique and highly effective theraputic agents. Learn about nanotechnology in cancer research

The use of nanotechnology for diagnosis and treatment of cancer is largely still in the development phase. However, there are already several nanocarrier-based drugs on the market and many more nano-based therapeutics in clinical trials. Read about current developments

The rest is here:
Learn About Nanotechnology in Cancer

Immortality – Cline Dion – VAGALUME

So this is who I am, And this is all I know, And I must choose to live, For all that I can give, The spark that makes the power grow

And I will stand for my dream if I can, Symbol of my faith in who I am, But you are my only, And I must follow on the road that lies ahead, And I won't let my heart control my head, But you are my only And we don't say goodbye, We don't say goodbye And I know what I've got to be

Immortality I make my journey through eternity I keep the memory of you and me, inside

Fulfill your destiny, Is there within the child, My storm will never end, My fate is on the wind, The king of hearts, the joker's wild, But we don't say goodbye, We don't say goodbye I'll make them all remember me

Cos I have found a dream that must come true, Every once of me must see it through, But you are my only I'm sorry I don't have a role for love to play, Hand over my heart I'll find my way, I will make them give to me

Immortality There is a vision and a fire in me I keep the memory of you and me, inside And we don't say goodbye We don't say goodbye With all my love for you And what else we may do We don't say, goodbye

The rest is here:
Immortality - Cline Dion - VAGALUME

Nanotechnology – US Forest Service Research & Development

Small and the Technology of Small

Nano is small, really, really, small. It comes from a Greek word meaning dwarf. One nanometer (nm) is one billionth of a meter (1 meter = 39.4 inches).

A nanometer is much, much smaller than a spot on a lady bug. An ant is about 5,000,000 nm (0.2 inches) long; human hair is about 100,000 nm (0.004 inches) wide; and an atom is approximately 1 nm.

Nanotechnology is the understanding and control of matter at dimensions between approximately 1 and 100 nanometers, where unique phenomena enable novel applications. Unusual physical, chemical, and biological properties can emerge in materials at the nanoscale. Nanotechnology also encompasses any nanoscale systems and devices and unique systems and devices that are involved in the manufacturing of nanoscale materials.

As an enabling technology, nanotechnology has the potential to benefit all aspects of forestry and forest products: from plants, forest management, harvesting, forest operations, wood-base products, application of wood-based products to the understanding of consumer behavior. In international conferences, scientists have briefly touched upon the ideas of using nanotechnology enabled products in resolving issue of international interest such as climate change (nanotechnology enabled sensors for example), energy efficiency (nanotechnology enabled catalysts for example) and water resources (nanotechnology enabled water harvesting for example). The forest products industry has identified nanotechnology as one of the technologies that will enable new products and product features.

The industry has goals to create new bio-based composites and nanomaterials, and to achieve improvement in the performance-to-weight ratio of paper and packaging products through nanotechnology and nanotechnology-enabled new paper features such as optical, electronic, barrier, sensing thermal and surface texture.

Due to its ability to reduce carbon footprints of petroleum based products, renewable forest-based nanocelluloses, together with other natural-occurring nanocelluloses, have been the subject of active research and development internationally. Often requested by user industries, nanocellulose has found its way in the research and development of plastics, coatings, sensors, electronics, automobile body and aerospace materials, medical implants and body armor. In the future, we can claim plastics, cellular telephones, medical implants, body armors and flexible displays as forest products.

Lux Research estimated that by 2015, US$3.1 trillion worth of products will have incorporated nanotechnology in their value chain. Successful realization of this technology using sustainable forest-based products will increase use of materials from renewable resources and decrease reliance on petroleum-based products and other non-renewable materials. With adequate investing in Forest Service nanotechnology R&D, the forest products industry envisions replacing the 300,000 jobs lost since 2006 with skilled workers, many of them in rural America - using materials we can grow, transport, and assemble into finished products in the United States more efficiently than nearly anywhere else in the world.

Continue reading here:
Nanotechnology - US Forest Service Research & Development